Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Elanco Animal Health Incorporated (ELAN) - Deadline is December 6, 2024
Via TheNewswire.com
Exposures Product Safety
FreezeNit Awarded Prestigious $25,000 AAP SOATT Pediatric Device Prize for Innovative Lice Treatment
Via PRLog
Exposures Product Safety
CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence"
Via PRLog
Exposures Product Safety
Tickers EB
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
Via Benzinga
Exposures Product Safety
Tickers BIIB LRMR PTC
A Rising Star on Ice: Meet 8-Year-Old Figure Skating Sensation Aalia Komizo Cheng
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Innovative Treatment Potentially Spares Kidneys in Adult Patients with Low-Grade Upper Tract Urothelial Cancer
Via Brandpoint
Exposures Product Safety
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
Via Benzinga
Exposures Product Safety
Tickers GSK
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Submits New Drug Application to FDA for TNX-102 SL for Fibromyalgia Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
Via Benzinga
Exposures Product Safety
Tickers NVAX
Bitcoin Rises While Ethereum, Dogecoin Stay Flat Amid Stock Reversal; ASML Struggles, Nvidia and AMD Recover; Stellantis Recalls 21K Hybrid SUVs Over Brake Pedal Issue - Top Headlines Today While US Slept
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers AMD NVDA SPY
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Stellantis Recalls Nearly 21K Plug-In Hybrid SUVs In US Over Concerns Of Brake Pedal Disengaging
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers NVCR
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Via The Motley Fool
Exposures Product Safety
Tickers LLY
Cher Wolf Design Group Announces Its "Hosting the Holidays!" Theme for 2024
Via PRLog
Topics Product Recall
Exposures Legal Product Safety
Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act
Via Press Release Distribution Service
Exposures Product Safety
Nano Hearing Aids' CEO Targets Key Global Markets With Ambitious Worldwide Tour
Via Press Release Distribution Service
Exposures Product Safety
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
Via Investor's Business Daily
Exposures Product Safety
Tickers BMY MRK NVCR
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance for Pivotal Phase 3 Alzheimer’s Trial, Launch Set for Early 2025
Via Investor Brand Network
Exposures Product Safety
Tickers ANVS
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
Via Benzinga
Exposures Product Safety
Tickers BAX
Las Vegas Eye Institute Clarifies Ideal Age for LASIK Surgery, Emphasizes Importance of Vision Stability
Via Press Advantage
Exposures Product Safety
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers HIMS LLY
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs
Via Benzinga
Exposures Product Safety
Tickers LLY
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Via Benzinga
Exposures Product Safety
Tickers PFE SGMO
Listeria Scare Prompts Albertsons To Recall Certain Ready-To-Eat Meals In Multiple States
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ACI FXG
Where Does Hims & Hers Stock Go From Here?
Via The Motley Fool
Exposures Product Safety
Tickers CVS HIMS WBA
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
Via Newsfile
Exposures Product Safety
Tickers ELTP
Introducing Garrett Shultz’s New Single: “You Over Me”
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
Via Benzinga
Exposures Product Safety
Tickers LLY NVO
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.